/Companies

Violet Therapeutics, Inc.

Cambridge, US · Founded 2021 · 7 known investors

Find your way into Violet Therapeutics, Inc.

Sign up to see every warm intro you have to Violet Therapeutics, Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Violet Therapeutics, Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Violet Therapeutics is a biotechnology company developing small molecule drugs for central nervous system and neurodegenerative diseases, using its C-to-C Engine to map cellular connectivity and signaling in CNS disorders. Its platform draws on neuroimmunology technologies including C-to-C Communication Maps, FIND-seq, and SPEAC-seq.

Founders & leadership

WE
William E YelleNamed on SEC filing
AU
Atsushi UsamiNamed on SEC filing
MF
Meredith FisherNamed on SEC filing
JB
Jonathan BehrNamed on SEC filing
FQ
Francisco QuintanaFounder
DS
Darby SchmidtChief Scientific Officer
DK
Dilip KodiraVP & Head of Platforms and Analytics

Investors · 7

Also in the syndicate · 1

Mass General Brigham Ventures (MGBV)

Funding

SEC filings, press & company announcements

$7.4M disclosed across 1 of 2 rounds · 2023

▶$7.4MraisedMay 2023 · 4 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • William E YelleExecutive Officer, Director
  • Atsushi UsamiDirector
  • Meredith FisherExecutive Officer, Director
  • Jonathan BehrDirector
Offering amount
$11.5M
Amount sold
$7.4M
First sale
Apr 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Violet Therapeutics, Inc. do?
Violet Therapeutics is a biotechnology company developing small molecule drugs for central nervous system and neurodegenerative diseases, using its C-to-C Engine to map cellular connectivity and signaling in CNS disorders. Its platform draws on neuroimmunology technologies including C-to-C Communication Maps, FIND-seq, and SPEAC-seq.
Who are Violet Therapeutics, Inc.'s investors?
Violet Therapeutics, Inc.'s investors include SV Health Investors, Dementia Discovery, Dementia Discovery Fund, Lifespan Vision Ventures, Ono Venture Investment, Inc., UTEC.
How much funding has Violet Therapeutics, Inc. raised?
Violet Therapeutics, Inc. has disclosed $7.4M raised across 1 of its 2 known rounds.
Where is Violet Therapeutics, Inc. headquartered?
Violet Therapeutics, Inc. is headquartered in Cambridge, US.